RDY Dr. Reddy’s Laboratories 12.77 USD -0.39% Score 6.9

These figures are from 2025-03-31. Nothing newer has been filed for Dr. Reddy’s Laboratories Ltd ADR in the 19 months since, so the score below is built on that year and not on the company as it stands today. Everything here is still the company's own filing, unchanged — every figure against the element it came from.

Market cap 11.83B

P/E TTM 17.6×

Forward P/E 0.31×

Revenue growth +13.7%

ROIC 15.6%

FCF yield 1.9%

Dr. Reddy’s Laboratories Ltd ADR (RDY)

12.77USD -0.39% (-0.05)

Over 5Y: +10.3%

Style

Area Line Line with markersshows 1Y Steps Candlesshows 6M Hollow candlesshows 6M Barsshows 6M

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

10 12.5 15

2022 2023 2024 2025 2026

Multiples & size

2025-03-31 · USD

Market cap 11.83Bp

P/E TTM 17.6×p

Forward P/E 0.31×e

EV/EBITDA 11.7×p

EV/EBIT 14.5×p

P/B 3.0×p

P/S TTM 3.1×p

EPS TTM 0.80

FCF yield 1.9%p

Dividend yield 0.66%p

Revenue growth +13.7%

Revenue CAGR +10.1%

Gross margin 58.5%

Operating margin 22.1%

Net margin 17.6%

FCF margin 5.9%

ROIC 15.6%

Payout 11.6%

Net debt/EBITDA 0.35×

52-week range

252 trading days

11.30 12.77 (37%) 15.23

Financials Annual

Figures

Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›

Dr. Reddy’s Laboratories Ltd ADR reported revenue of 3.8B USD for the year ending 31 March 2025, up 13.8% from 3.4B a year earlier. Every figure, period by period ›

0 800M 1.6B 2.4B 3.2B 4B

FY21 FY22 FY23 FY24 FY25

Revenue Operating Cash Flow Free Cash Flow Net Income

5-year valuation

1143 trading days

Price to Earnings 8^th pct

16.3×

0th14.8× 25th17.2× 50th19.0× 75th25.8× 100th40.9×

Price to Sales 15^th pct

2.9×

0th2.6× 25th2.9× 50th3.2× 75th3.5× 100th4.1×

Price to Operating Cash Flow 38^th pct

20.1×

0th11.4× 25th17.1× 50th21.0× 75th22.0× 100th25.3×

Price to Free Cash Flow 78^th pct

49.1×

0th14.1× 25th23.6× 50th37.4× 75th47.9× 100th59.5×

Price to Book 2^nd pct

2.8×

0th2.6× 25th3.1× 50th3.3× 75th3.7× 100th4.3×

EV / EBITDA 5^th pct

10.4×

0th9.5× 25th11.2× 50th12.4× 75th14.5× 100th18.8×

Price at its own multiples

today 13.13

At its median price to earnings of 19.0× 15.30 (+16.5%)

low 11.94high 32.90

At its median price to sales of 3.2× 14.43 (+10.0%)

low 11.73high 18.84

At its median price to operating cash flow of 21.0× 13.72 (+4.5%)

low 7.42high 16.56

At its median price to free cash flow of 37.4× 9.99 (-23.9%)

low 3.76high 15.91

At its median price to book of 3.3× 15.40 (+17.3%)

low 12.16high 20.00

What the share would cost today if the market paid the same multiple of the same figures as it has over five years. The band is where it traded half the time, the line its median, the dot today’s price. A multiple a company has outgrown or fallen below is not a promise to return to it. Project it forward ›

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.0

SBC / sales 0.13%

Capex / sales 8.4%

ROCE 19.8%

SG&A / sales 28.8%

Gross margin 58.5%

Profit margin 17.6%

Adj. EBITDA margin 27.5%

Accruals 2.2%

EBITDA margin 27.3%

Oper. margin 22.1%

DSO 101.3 days

OCF margin 14.3%

Asset turnover 0.66×

ROA 11.6%

OCF / EBIT 0.65×

ROIC 15.6%

ROE 17.2%

OE margin 5.7%

FCF margin 5.9%

19 of 19 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

6.4

Fwd P/E 0.31×

PEG 0.00094×

P/B 3.0×

EV/GP 5.5×

EV/EBIT 14.5×

P/E 17.6×

EV/OE 55.9×

FCF yield 1.9%

Div. yield 0.66%

P/C 68.8×

Shareholder yield 0.66%

EV/Sales 3.2×

11 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

7.3

Revenue growth in the worst year on record 5.9%

Cash-flow margin stability 3.5 pp

Gross margin stability across years 2.2 pp

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.4

Interest cover 25.5×

Retained / assets 64.1%

Equity / Assets 67.6%

Net debt / Eq 0.094×

Debt / Eq 0.14×

Payout 11.6%

ND/EBITDA -0.03

Debt payback 1.6 yr

Current ratio 1.9×

Cash / Debt 0.32×

Quick ratio 1.4×

F-score 2.0 pts

12 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.1

EPS next Y +326.8%

Operating margin trend 2.3

Most recent margin move 0.76

Shares change +0.077%

EBIT CAGR +26.2%

Gross profit Y/Y +13.6%

Sales/sh Y/Y +13.7%

Sales CAGR 4Y +10.1%

EBIT Y/Y +3.6%

EPS Y/Y +0.37%

Div. growth -2.5%

11 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.